ES215631A1 - UN MÉTODO DE FABRICAR UN COMPUESTO MEDICINAL QUE TIENE UN PERiODO DE DESINTEGRACIoN PREDETERMINADO - Google Patents

UN MÉTODO DE FABRICAR UN COMPUESTO MEDICINAL QUE TIENE UN PERiODO DE DESINTEGRACIoN PREDETERMINADO

Info

Publication number
ES215631A1
ES215631A1 ES0215631A ES215631A ES215631A1 ES 215631 A1 ES215631 A1 ES 215631A1 ES 0215631 A ES0215631 A ES 0215631A ES 215631 A ES215631 A ES 215631A ES 215631 A1 ES215631 A1 ES 215631A1
Authority
ES
Spain
Prior art keywords
therapeutic tablets
translation
differ
kinds
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0215631A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOWAY HANS
Original Assignee
LOWAY HANS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOWAY HANS filed Critical LOWAY HANS
Publication of ES215631A1 publication Critical patent/ES215631A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)

Abstract

Método de fabricar un compuesto medicinal moldeado, que tiene un periodo de desintegración predeterminado, caracterizado por el hecho de prepararse una pluralidad de gránulos terapéuticamente activos, de dos clases, por lo menos, que difieren en sus periodos de dispersión.
ES0215631A 1953-06-03 1954-05-29 UN MÉTODO DE FABRICAR UN COMPUESTO MEDICINAL QUE TIENE UN PERiODO DE DESINTEGRACIoN PREDETERMINADO Expired ES215631A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US359421A US2953497A (en) 1953-06-03 1953-06-03 Therapeutic tablets

Publications (1)

Publication Number Publication Date
ES215631A1 true ES215631A1 (es) 1954-12-01

Family

ID=23413726

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0215631A Expired ES215631A1 (es) 1953-06-03 1954-05-29 UN MÉTODO DE FABRICAR UN COMPUESTO MEDICINAL QUE TIENE UN PERiODO DE DESINTEGRACIoN PREDETERMINADO

Country Status (3)

Country Link
US (1) US2953497A (es)
DE (1) DE1292783B (es)
ES (1) ES215631A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
CH434571A (de) * 1966-07-05 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
US3485914A (en) * 1966-07-05 1969-12-23 Chem & Pharm Patent Hold Ltd Process for the production of a pharmaceutical antibiotic preparation having delayed therapeutic action and the composition prepared according to such process
US3683926A (en) * 1970-07-09 1972-08-15 Dainippon Pharmaceutical Co Tube for connecting blood vessels
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
US4012498A (en) * 1974-03-27 1977-03-15 Sandoz, Inc. Sustained release tablet formulations
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
CH647676A5 (fr) * 1978-12-22 1985-02-15 Donald E Panoz Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
GB2058562B (en) * 1979-09-14 1983-11-30 Beecham Group Ltd Pharmaceutical compositions containing paracetamol and ascorbic acid
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
NZ195933A (en) * 1980-01-11 1982-11-23 Boots Co Ltd Sustained-release pharmaceutical compositions in tablet form
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US4961932A (en) * 1987-10-26 1990-10-09 Alza Corporation Plurality of tiny pills in liquid dosage form
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US6361796B1 (en) * 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
JP4863534B2 (ja) * 1996-10-25 2012-01-25 スパーナス ファーマシューティカルズ インコーポレイテッド 可溶形態浸透用量送達システム
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT130794B (de) * 1932-12-10 Pharma Eutische Werke Norgine Verfahren zur Herstellung von Pillen, Pastillen od. dgl.
GB285091A (en) * 1927-02-12 1929-06-10 Siegwart Hermann Process for the production of pills and pastilles for the small intestine
US2099403A (en) * 1934-11-24 1937-11-16 Pratt Food Company Split action tablet
DE699574C (de) * 1935-09-20 1941-03-01 Zinsser & Co Dr Verfahren zur Herstellung eines Arzneimittels in koerniger oder kugeliger Form
US2195596A (en) * 1936-11-07 1940-04-02 Squibb & Sons Inc Protected-vitamin-containing tablet
US2146867A (en) * 1937-06-07 1939-02-14 Welin Sater Company Medicinal preparation and method of making the same
FR911180A (fr) * 1945-02-05 1946-07-01 Inter Trade Trust Procédé de préparation d'un mélange destiné à l'obtention d'un liquide effervescent et mélange obtenu par mise en oeuvre de ce procédé
GB618542A (en) * 1946-09-06 1949-02-23 Brewer & Company Inc Improvements in methods of making tablets
DE859519C (de) * 1951-06-21 1952-12-15 Adefo Chemie G M B H Verfahren zur Herstellung von Brausetabletten mit antineuralgischen Wirkstoffen
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
DE1001456B (de) * 1953-02-27 1957-01-24 Smith Kline & French Internat Verfahren zur Herstellung einer oral anzuwendenden Arzneiform mit Depotwirkung

Also Published As

Publication number Publication date
DE1292783B (de) 1969-04-17
US2953497A (en) 1960-09-20

Similar Documents

Publication Publication Date Title
ES215631A1 (es) UN MÉTODO DE FABRICAR UN COMPUESTO MEDICINAL QUE TIENE UN PERiODO DE DESINTEGRACIoN PREDETERMINADO
ES360946A1 (es) Mejoras en la fabricacion de dispositivos anulares elasti- cos medicados para uso intravaginal en mamiferos hembras.
CH303828A (de) Tabletten-Zuführtrichter.
ES35908U (es) Preparado de plantas aromáticas
ES306708A1 (es) Procedimiento en y relacionado con la obtenciën de taraceas ornamentales regulares
ES335038A1 (es) Procedimiento para la produccion de una preparacion farma- ceutica teniendo actividad farmaceutica sostenida.
ES33975U (es) Nuevos troqueles para la fabricación de piezas dentarias
ES222263A2 (es) UN PROCEDIMIENTO DE FABRICACIoN DE DERIVADOS DE 1-FENIL-2,2-BIS(DIETILAMINOMETIL)-ETANO
ES307294A1 (es) Procedimiento de fabricacion de un preventivo para enfermedades de las plantas
ES207592A1 (es) Un procedimiento para la obtención rápida de coquillas para moldeo por inyección, así como de matrices y de moldes en general
ES26314U (es) Elementos de construcción perfeccionados en la disposición de sus huecos interiores
CA496011A (en) Athletic ball
ES56979U (es) Estuche perfeccionado para comprimidos
ES71448U (es) Juego rompecabezas perfeccionado
ES262756A1 (es) Procedimiento y dispositivo para la fabricaciën de dados
ES221314A1 (es) Un procedimiento para la fabricación de un producto raticida
ES236487A1 (es) Perfeccionamientos introducidos en los ditribuidores de fabricante para intalaciones de engrase central
ES40584U (es) Calzado perfeccionado
ES226555A3 (es) UN PROCEDIMIENTO PARA LA FABRICACIoN DE AGLOMERADOS DE SARMIENTOS DE VIDES O ANáLOGOS
ES270541A3 (es) Dispositivo de dibujo en, máquinas tricotosas circulares
AU291863B2 (en) Manufacture of needles for baling machinery
ES67590U (es) Estructura para la fabricación de calzado
ES35935U (es) Nuevo modelo de juego de ajedrez
AU220815B2 (en) An improved needle-bed plate for knitting machines anda method of production thereof
ES36946U (es) Molde para la elaboración y vulcanización de calzado todo goma